Revusiran (sodium)
Revusiran sodium is a 1st-generation short interfering RNA, which directed against transthyretin (TTR) mRNA. Revusiran sodium can be used for transthyretin (TTR) -mediated amyloidosis research[1].
Product Specifications
Product Name Alternative
ALN-TTRSC (sodium)
UNSPSC
12352208
Target
Small Interfering RNA (siRNA) ; Transthyretin (TTR)
Type
Oligonucleotides
Related Pathways
Epigenetics; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/revusiran-sodium.html
Purity
93.16
Solubility
10 mM in H2O
Smiles
[Revusiran(sodium)]
Molecular Weight
16121 (free acid)
References & Citations
[1]Jessica E Sutherland, et al. Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis. Nucleic Acid Ther. 2020 Feb;30 (1) :33-49.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6237245-01 0.1 mL
ART3 (ADP-Ribosyltransferase 3, FLJ26404) (MaxLight 750)
Sign In for Pricing
View Details MBS6237245-02 5x 0.1 mL
ART3 (ADP-Ribosyltransferase 3, FLJ26404) (MaxLight 750)
Sign In for Pricing
View Details MBS1339380-01 0.02 mg (E-Coli)
Recombinant Pongo abelii TSC22 domain family protein 3 (TSC22D3)
Sign In for Pricing
View Details 
MBS1339380-02 0.1 mg (E-Coli)
Recombinant Pongo abelii TSC22 domain family protein 3 (TSC22D3)
Sign In for Pricing
View Details MBS1339380-03 0.02 mg (Yeast)
Recombinant Pongo abelii TSC22 domain family protein 3 (TSC22D3)
Sign In for Pricing
View Details